2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with Diabetes Mellitus, Type 2 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bach Knudsen, KE; Eriksen, AK; Frederiksen, K; Kyrø, C; Landberg, R; Nørskov, NP; Olsen, A; Overvad, K; Tjønneland, A | 1 |
Cassidy, A; Franke, AA; Hu, FB; Pan, A; Rimm, EB; Sun, Q; Townsend, MK; van Dam, RM; Wedick, NM | 1 |
Franke, AA; Hu, FB; Hu, Y; Song, Y; Sun, Q; van Dam, RM | 1 |
3 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Pre-diagnostic plasma enterolactone concentrations are associated with lower mortality among individuals with type 2 diabetes: a case-cohort study in the Danish Diet, Cancer and Health cohort.
Topics: 4-Butyrolactone; Aged; Case-Control Studies; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Lignans; Male; Middle Aged; Neoplasms; Prognosis; Random Allocation | 2019 |
Gut microbiota metabolites of dietary lignans and risk of type 2 diabetes: a prospective investigation in two cohorts of U.S. women.
Topics: 4-Butyrolactone; Adult; Case-Control Studies; Diabetes Mellitus, Type 2; Diet; Female; Humans; Lignans; Microbiota; Middle Aged; Prospective Studies; Risk Factors | 2014 |
A Prospective Investigation of the Association Between Urinary Excretion of Dietary Lignan Metabolites and Weight Change in US Women.
Topics: 4-Butyrolactone; Adult; Aged; Body Weight; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Incidence; Lignans; Middle Aged; Prospective Studies; United States; Urinalysis | 2015 |